13F
← All fund report cards

Artemis Investment Management LLP

13F equity value
$9.4B
Positions
203
Top 10 concentration
22.5%
Quarters / total new picks
32 / 1,063
13F equity value over time
$0M$30B$59B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.0% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 59.4% of quarters (excess t = 1.33, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.1%
t-stat
1.33
Quarterly win rate
59%
Annualized excess
+1.2%
$1 → follow vs universe
$2.27 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.04820180630: follow 0.96620180930: follow 1.04920181231: follow 1.04820190331: follow 1.05320190630: follow 1.15220190930: follow 1.24220191231: follow 1.09820200331: follow 1.30020200630: follow 1.33220200930: follow 1.57020201231: follow 1.72520210331: follow 1.73820210630: follow 1.92820210930: follow 1.69420211231: follow 1.41920220331: follow 1.43920220630: follow 1.35220220930: follow 1.40320221231: follow 1.33520230331: follow 1.40620230630: follow 1.38920230930: follow 1.57320231231: follow 1.72120240331: follow 1.76120240630: follow 1.93720240930: follow 1.86520241231: follow 1.78020250331: follow 1.83420250630: follow 1.81020250930: follow 2.14320251231: follow 2.270 0.84 1.64 2.45 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 203 · 2026 Q1

Ticker Value Weight QoQ
AZN $281M
3.0%
NEW
NVDA $262M
2.8%
TRIM
ABBV $227M
2.4%
ADD
CSCO $219M
2.3%
ADD
PFE $208M
2.2%
ADD
KGC $205M
2.2%
ADD
DOW $198M
2.1%
NEW
GOOGL $178M
1.9%
TRIM
BMY $175M
1.9%
ADD
FCX $166M
1.8%
ADD
PAGP $163M
1.7%
ADD
AEM $154M
1.6%
ADD
FHN $131M
1.4%
ADD
JBHT $129M
1.4%
NEW
PRIM $126M
1.3%
ADD
GM $122M
1.3%
TRIM
COHR $121M
1.3%
ADD
NVT $119M
1.3%
TRIM
AAPL $119M
1.3%
TRIM
BEN $115M
1.2%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.